Mitsunaga K, Bagot M, Ram-Wolff C, Guenova E, et al. Real-world study of pegylated interferon alpha-2a to treat mycosis fungoides/Sezary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study. Br J Dermatol 2024;191:419-427.
PMID: 38596857